|
|
Level 2, 369 Royal Parade
Parkville South Melbourne, VIC 3052 Australia
phone:61 3 9349 4906
fax:61 3 9348 0377
|
|
| Symbol |
PRAN |
| Exchange |
NASDAQ |
| Founded |
1997 |
| Employees |
|
|
|
| www.pranabio.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Addressing role of biological metals in diseases |
|
| Management |
| Mr Geoffrey Kempler, Executive Chairman, Chief Executive Officer; Ms Dianne Angus, Chief Operating Officer; Mr Geoffrey Kempler, Executive Chairman, Chief Executive Officer; Dr George Mihaly, Non-executive Director; Mr Brian Meltzer, Non-executive Director |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| neurological, alzheimer, arkinson, huntington�s diseases, biotechnology |
|
|
|
|
|
|
| Description |
|
Established in 1997, Prana Biotechnology is a world leader in addressing the role of biological metals in human disease. Abundant scientific evidence suggests that many age-related conditions result from pathological interactions between selected metals and target proteins. The company has developed a proprietary library of chemical compounds that target these interactions, preventing protein aggregation and corruption. The mission of the company is to develop disease modifying therapeutics for the treatment of common neurological disorders, with a focus upon Alzheimer's, Parkinson's and Huntington's diseases. Other potential applications for this platform technology include specific cancers and Age-related Macular Degeneration. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members